Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is a minimally invasive procedure that has proven to be safe and effective for treating symptomatic gallbladder disease in patients with cirrhosis. Cirrhotic patients are traditionally considered high-risk for surgical procedures due to their compromised liver function, increased bleeding risk, and susceptibility to complications.
Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is a minimally invasive procedure that has proven to be safe and effective for treating symptomatic gallbladder disease in patients with cirrhosis. Cirrhotic patients are traditionally considered high-risk for surgical procedures due to their compromised liver function, increased bleeding risk, and susceptibility to complications. EUS-GBD provides an alternative to surgery, offering relief from gallbladder-related symptoms and inflammation without the need for more invasive interventions.
A multicenter study compared outcomes of EUS-GBD in cirrhotic (47 patients) and non-cirrhotic (123 patients) individuals. Both groups showed similar rates of technical success (97.9% vs. 95.1%) and clinical success (93.6% vs. 94.9%), with rare adverse events and comparable survival rates. Acute cholecystitis was more prevalent in cirrhotic patients, reflecting their higher disease burden. Overall, EUS-GBD demonstrated equivalent safety and effectiveness in cirrhotic and non-cirrhotic patients, establishing it as a viable option for gallbladder drainage in cirrhosis.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.